BB Biotech AG/ CH0038389992 /
29/04/2024 17:11:13 | Chg. +0.75 | Volume | Bid17:20:00 | Ask17:20:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.20CHF | +1.85% | 1,625 Turnover: 66,164.40 |
-Bid Size: - | -Ask Size: - | 2.29 bill.CHF | 4.85% | - |
GlobeNewswire
28/03
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire
17/06/2021
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
GlobeNewswire
16/12/2019
Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire
19/10/2018
Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire
02/01/2018
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire
19/10/2017
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire
02/12/2016
Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire
29/07/2016
Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire
15/07/2016
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire
14/07/2016
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...